Anhui Provincial Cancer Hospital

This study tests a new drug, QL1706, which blocks two immune checkpoints (PD-1 and CTLA-4) at once, combined with standard chemotherapy for people with advanced non-small cell lung cancer that no longer responds to initial immunotherapy. About 96 adults whose tumors lack certain …

This study tests a new type of radiation surgery called hypervision proton surgery for people with early-stage non-small cell lung cancer. The goal is to see if it is safe and can control the tumor using one or two high-dose treatments. About 12 participants will be followed for …

This study tests whether adding an immunotherapy drug (tislelizumab) to standard chemotherapy and radiation can help people with extensive small cell lung cancer live longer without their cancer growing. About 56 adults who have not had prior treatment for this advanced lung canc…

This study tests a new, noninvasive finger imaging device to see if it can detect and tell apart two types of heart valve disease: aortic regurgitation and aortic stenosis. About 15 adults—including healthy volunteers and those with known valve disease—will place a finger in the …